Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$8.33 - $11.89 $234,089 - $334,132
-28,102 Reduced 13.89%
174,266 $2.04 Million
Q3 2023

Oct 25, 2023

SELL
$9.63 - $13.36 $128,079 - $177,688
-13,300 Reduced 6.17%
202,368 $2 Million
Q1 2023

May 08, 2023

SELL
$8.11 - $10.53 $57,605 - $74,794
-7,103 Reduced 3.19%
215,668 $2.25 Million
Q3 2022

Nov 09, 2022

SELL
$8.4 - $28.4 $136,063 - $460,023
-16,198 Reduced 6.78%
222,771 $1.96 Million
Q2 2022

Aug 09, 2022

BUY
$10.78 - $15.5 $2.58 Million - $3.7 Million
238,969 New
238,969 $2.86 Million
Q1 2022

Apr 21, 2022

SELL
$12.93 - $23.46 $3.88 Million - $7.04 Million
-300,288 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$22.0 - $25.77 $6.61 Million - $7.74 Million
300,288 New
300,288 $7.13 Million

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.62B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.